MedTrace Logo

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

NCT05848817 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-07-17

Study results available
· View outcomes & findings →

Summary

The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.

Conditions

  • Myopia

Interventions

DEVICE

Contoura LASIK

Subjects receiving Phorcides Planned Contoura LASIK

Sponsors & Collaborators

  • Sengi

    collaborator INDUSTRY

  • Mann Eye Institute

    lead OTHER

Principal Investigators

  • Phillip Brunson, OD · Mann Eye Institute

Eligibility

Min Age
21 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-19
Primary Completion
2024-08-15
Completion
2024-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05848817 on ClinicalTrials.gov